Modulation of peroxisome proliferator-activated receptor-α activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures

Journal of Neurochemistry

Volumn 105, Issue 3, 2008, Pages 956-970

  Paintlia, Manjeet K ^a   Paintlia, Ajaib S ^a   Khan, Mushfiquddin ^a   Singh, Inderjit ^a   Singh, Avtar K ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cerebral white matter injury; Lipopolysaccharide; Oligodendrocyte; Peroxisome proliferator activated receptor and N acetyl cysteine; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; CYTOKINE; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIA CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; WHITE MATTER;

ACETYLCYSTEINE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE TRANSMISSION, VERTICAL; DOWN-REGULATION; ENCEPHALITIS; FREE RADICAL SCAVENGERS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; OLIGODENDROGLIA; OXIDATIVE STRESS; PEROXISOMES; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; STEM CELLS;

MUS;

EID: 42449118547     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05199.x     Document Type: Article

References (67)

1. Back S. A. Rivkees S. A. (2004) Emerging concepts in periventricular white matter injury. Semin. Perinatol. 28, 405 414.
2. Back S. A., Han B. H., Luo N. L., Chricton C. A., Xanthoudakis S., Tam J., Arvin K. L. Holtzman D. M. (2002) Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J. Neurosci. 22, 455 463.
3. Bahat-Stroomza M., Gilgun-Sherki Y., Offen D., Panet H., Saada A., Krool-Galron N., Barzilai A., Atlas D. Melamed E. (2005) A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease. Eur. J. Neurosci. 21, 637 646.
4. Baumgart E., Vanhorebeek I., Grabenbauer M., Borgers M., Declercq P. E., Fahimi H. D. Baes M. (2001) Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am. J. Pathol. 159, 1477 1494.
5. Beck S., Lambeau G., Scholz-Pedretti K., Gelb M. H., Janssen M. J., Edwards S. H., Wilton D. C., Pfeilschifter J. Kaszkin M. (2003) Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation. J. Biol. Chem. 278, 29799 29812.
6. Bell M. J., Hallenbeck J. M. Gallo V. (2004) Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr. Res. 56, 541 546.
7. Cabrero A., Alegret M., Sanchez R. M., Adzet T., Laguna J. C. Carrera M. V. (2002) Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells. J. Biol. Chem. 277, 10100 10107.
8. Cabrero A., Merlos M., Laguna J. C. Carrera M. V. (2003) Down-regulation of acyl-CoA oxidase gene expression and increased NF-kappaB activity in etomoxir-induced cardiac hypertrophy. J. Lipid Res. 44, 388 398.
9. Cai Z., Pan Z. L., Pang Y., Evans O. B. Rhodes P. G. (2000) Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr. Res. 47, 64 72.
10. Corton J. C., Anderson S. P. Stauber A. (2000) Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40, 491 518.
11. Dammann O. Leviton A. (1997) Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr. Res. 42, 1 8.
12. Dammann O. Leviton A. (2000) Role of the fetus in perinatal infection and neonatal brain damage. Curr. Opin. Pediatr. 12, 99 104.
13. Deplanque D., Gele P., Petrault O. et al. (2003) Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J. Neurosci. 23, 6264 6271.
14. Elias E. R., Mobassaleh M., Hajra A. K. Moser A. B. (1998) Developmental delay and growth failure caused by a peroxisomal disorder, dihydroxyacetonephosphate acyltransferase (DHAP-AT) deficiency. Am. J. Med. Genet. 80, 223 226.
15. Fidel Jr. P. L., Romero R., Wolf N., Cutright J., Ramirez M., Araneda H. Cotton D. B. (1994) Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am. J. Obstet. Gynecol. 170, 1467 1475.
16. Gregori N., Proschel C., Noble M. Mayer-Proschel M. (2002) The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function. J. Neurosci. 22, 248 256.
17. Hagberg H., Mallard C. Jacobsson B. (2005) Role of cytokines in preterm labour and brain injury. BJOG 112 (Suppl. 1 16 18.
18. Haynes R. L., Folkerth R. D., Keefe R. J., Sung I., Swzeda L. I., Rosenberg P. A., Volpe J. J. Kinney H. C. (2003) Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J. Neuropathol. Exp. Neurol. 62, 441 450.
19. Haynes R. L., Baud O., Li J., Kinney H. C., Volpe J. J. Folkerth D. R. (2005) Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol. 15, 225 233.
20. Jatana M., Singh I., Singh A. K. Jenkins D. (2006) Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr. Res. 59, 684 689.
21. Juurlink B. H., Thorburne S. K. Hertz L. (1998) Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 22, 371 378.
22. Kassmann C. M., Lappe-Siefke C., Baes M. et al. (2007) Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 39, 969 976.
23. Khan M., Contreras M. Singh I. (2000) Endotoxin-induced alterations of lipid and fatty acid compositions in rat liver peroxisomes. J Endotoxin Res. 6, 41 50.
24. Khan M., Sekhon B., Jatana M., Giri S., Gilg A. G., Sekhon C., Singh I. Singh A. K. (2004) Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J. Neurosci. Res. 76, 519 527.
25. Khan M., Haq E., Giri S., Singh I. Singh A. K. (2005) Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease. J. Neurosci. Res. 80, 845 854.
26. Kinney H. C. Back S. A. (1998) Human oligodendroglial development: relationship to periventricular leukomalacia. Semin. Pediatr. Neurol. 5, 180 189.
27. Kumagai T., Matsukawa N., Kaneko Y., Kusumi Y., Mitsumata M. Uchida K. (2004) A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J. Biol. Chem. 279, 48389 48396.
28. Lavrovsky Y., Chatterjee B., Clark R. A. Roy A. K. (2000) Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp. Gerontol. 35, 521 532.
29. Lazarow P. B. (1995) Peroxisome structure, function, and biogenesis - human patients and yeast mutants show strikingly similar defects in peroxisome biogenesis. J. Neuropathol. Exp. Neurol. 54, 720 725.
30. Lazarow P. B. (2003) Peroxisome biogenesis: advances and conundrums. Curr. Opin. Cell Biol. 15, 489 497.
31. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P. L., Jensen F. E., Rosenberg P. A., Volpe J. J. Vartanian T. (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22, 2478 2486.
32. Levison S. W., Rothstein R. P., Romanko M. J., Snyder M. J., Meyers R. L. Vannucci S. J. (2001) Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells. Dev. Neurosci. 23, 234 247.
33. Leviton A. Gilles F. (1996) Ventriculomegaly, delayed myelination, white matter hypoplasia, and 'periventricular' leukomalacia: how are they related? Pediatr. Neurol. 15, 127 136.
34. Millan-Plano S., Garcia J. J., Martinez-Ballarin E., Reiter R. J., Ortega-Gutierrez S., Lazaro R. M. Escanero J. F. (2003) Melatonin and pinoline prevent aluminium-induced lipid peroxidation in rat synaptosomes. J. Trace Elem. Med. Biol. 17, 39 44.
35. Min K. J., Yang M. S., Kim S. U., Jou I. Joe E. H. (2006) Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. J. Neurosci. 26, 1880 1887.
36. Moser H. W. (1996) Peroxisomal disorders. Semin. Pediatr. Neurol. 3, 298 304.
37. Moser H. W. (1999) Peroxisomal disorders: classification and overview of biochemical abnormalities. Rev. Neurol. 28 (Suppl. 1 S45 S48.
38. Moynagh P. N., Williams D. C. O'Neill L. A. (1994) Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. J. Immunol. 153, 2681 2690.
39. Paintlia A. S., Gilg A. G., Khan M., Singh A. K., Barbosa E. Singh I. (2003) Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiol. Dis. 14, 425 439.
40. Paintlia M. K., Paintlia A. S., Barbosa E., Singh I. Singh A. K. (2004) N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J. Neurosci. Res. 78, 347 361.
41. Paintlia A. S., Paintlia M. K., Khan M., Vollmer T., Singh A. K. Singh I. (2005) HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB J. 19, 1407 1421.
42. Paintlia A. S., Paintlia M. K., Singh I. Singh A. K. (2006) IL-4-induced peroxisome proliferator-activated receptor gamma activation inhibits NF-kappaB trans activation in central nervous system (CNS) glial cells and protects oligodendrocyte progenitors under neuroinflammatory disease conditions: implication for CNS-demyelinating diseases. J. Immunol. 176, 4385 4398.
43. Pang Y., Cai Z. Rhodes P. G. (2005) Effect of tumor necrosis factor-alpha on developing optic nerve oligodendrocytes in culture. J. Neurosci. Res. 80, 226 234.
44. Poynter M. E. Daynes R. A. (1998) Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 273, 32833 32841.
45. Qi C., Zhu Y. Reddy J. K. (2000) Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell Biochem. Biophys. 32 (Spring), 187 204.
46. Santos M. J., Quintanilla R. A., Toro A., Grandy R., Dinamarca M. C., Godoy J. A. Inestrosa N. C. (2005) Peroxisomal proliferation protects from beta-amyloid neurodegeneration. J. Biol. Chem. 280, 41057 41068.
47. Schrader M. Fahimi H. D. (2006) Peroxisomes and oxidative stress. Biochim. Biophys. Acta 1763, 1755 1766.
48. Sekhon B., Sekhon C., Khan M., Patel S. J., Singh I. Singh A. K. (2003) N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res. 971, 1 8.
49. Sheikh F. G., Pahan K., Khan M., Barbosa E. Singh I. (1998) Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Proc. Natl Acad. Sci. USA, 95, 2961 2966.
50. Sher T., Yi H. F., McBride O. W. Gonzalez F. J. (1993) cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32, 5598 5604.
51. Siems W. G., Grune T., Beierl B., Zollner H. Esterbauer H. (1992) The metabolism of 4-hydroxynonenal, a lipid peroxidation product is dependent on tumor age in Ehrlich mouse ascites cells. EXS 62, 124 135.
52. Singh I. (1997) Biochemistry of peroxisomes in health and disease. Mol. Cell. Biochem. 167, 1 29.
53. Singh I., Pahan K., Khan M. Singh A. K. (1998) Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J. Biol. Chem. 273, 20354 20362.
54. Singh I., Paintlia A. S., Khan M., Stanislaus R., Paintlia M. K., Haq E., Singh A. K. Contreras M. A. (2004) Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment. Brain Res. 1022, 1 11.
55. Stanislaus R., Gilg A. G., Singh A. K. Singh I. (2005) N-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis rats. J Autoimmune Dis. 2, 4.
56. Sztriha L. S., Nork M. P., Abdulrazzaq Y. M., al-Gazali L. I. Bakalinova D. B. (1997) Abnormal myelination in peroxisomal isolated dihydroxyacetonephosphate acyltransferase deficiency. Pediatr. Neurol. 16, 232 236.
57. Topal T., Oter S., Korkmaz A., Sadir S., Metinyurt G., Korkmazhan E. T., Serdar M. A., Bilgic H. Reiter R. J. (2004) Exogenously administered and endogenously produced melatonin reduce hyperbaric oxygen-induced oxidative stress in rat lung. Life Sci. 75, 461 467.
58. Toyokuni S., Uchida K., Okamoto K., Hattori-Nakakuki Y., Hiai H. Stadtman E. R. (1994) Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl Acad. Sci. USA 91, 2616 2620.
59. Tsuji F., Miyake Y., Aono H., Kawashima Y. Mita S. (1999) Effects of bucillamine and N-acetyl-L-cysteine on cytokine production and collagen-induced arthritis (CIA). Clin. Exp. Immunol. 115, 26 31.
60. Uchida K. (2003) 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 42, 318 343.
61. Uchida K. Stadtman E. R. (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. J. Biol. Chem. 268, 6388 6393.
62. Van den Branden C., Dacremont G., Hooghe R. Roels F. (1989) Inhibition of peroxisomal beta-oxidation and brain development in rats. Glia 2, 260 265.
63. Van den Branden C., Leeman J., Dacremont G., Collumbien R. Roels F. (1990) Experimental inhibition of peroxisomal beta-oxidation in rats: influence on brain myelination. Glia 3, 458 463.
64. Victor V. M., Rocha M. De la Fuente M. (2003) N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic. Res. 37, 919 929.
65. Wang X., Rousset C. I., Hagberg H. Mallard C. (2006) Lipopolysaccharide- induced inflammation and perinatal brain injury. Semin. Fetal Neonatal Med. 11, 343 353.
66. Yoon B. H., Kim C. J., Romero R., Jun J. K., Park K. H., Choi S. T. Chi J. G. (1997a) Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am. J. Obstet. Gynecol. 177, 797 802.
67. Yoon B. H., Romero R., Kim C. J., Koo J. N., Choe G., Syn H. C. Chi J. G. (1997b) High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am. J. Obstet. Gynecol. 177, 406 411.